Volume-based growth tumor kinetics as a prognostic biomarker for patients with EGFR mutant lung adenocarcinoma undergoing EGFR tyrosine kinase inhibitor therapy: a case control study
about
The prognostic value of CT radiomic features for patients with pulmonary adenocarcinoma treated with EGFR tyrosine kinase inhibitors.Mechanistic modeling quantifies the influence of tumor growth kinetics on the response to anti-angiogenic treatment.mouse study identifies tumour growth kinetics as biomarkers for the outcome of anti-angiogenic treatment
P2860
Volume-based growth tumor kinetics as a prognostic biomarker for patients with EGFR mutant lung adenocarcinoma undergoing EGFR tyrosine kinase inhibitor therapy: a case control study
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Volume-based growth tumor kine ...... therapy: a case control study
@ast
Volume-based growth tumor kine ...... therapy: a case control study
@en
type
label
Volume-based growth tumor kine ...... therapy: a case control study
@ast
Volume-based growth tumor kine ...... therapy: a case control study
@en
prefLabel
Volume-based growth tumor kine ...... therapy: a case control study
@ast
Volume-based growth tumor kine ...... therapy: a case control study
@en
P2093
P2860
P1433
P1476
Volume-based growth tumor kine ...... therapy: a case control study
@en
P2093
Ho Yun Lee
Ji Hyun Lee
Jin Seok Ahn
Jong-Mu Sun
Keunchil Park
Kyung Soo Lee
Myung-Ju Ahn
P2860
P2888
P356
10.1186/S40644-016-0063-7
P577
2016-03-16T00:00:00Z
P5875
P6179
1023180415